Eris Lifesciences has pre-paid the entire loan facility obtained from Axis bank. The Loan Facility Agreements dated November 30, 2017 with Axis bank therefore stand closed/terminated.
Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.